- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Snapshot for Phylogica Ltd (PH7)
| Open: | 0.015 | Day's Range: | 0.005 - 0.015 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.015 | 52wk Range: | 0.001 - 0.041 | 1-Yr Rtn: | -86.84% |
Key Statistics for PH7
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (06/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/21/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PH7
Company Profile & Key Executives for PH7
Phylogica Limited is a biopharmaceutical company that utilizes proprietary drug discovery technologies to discover and develop novel peptide therapeutics.
| John Douglas Wilson "Doug"Non-Executive Chairman | Paul Michael WattCEO/Executive Director |
| Richard Miles HopkinsChief Operating Officer | Nicholas L Woolf "Nick"VP:Corporate Dev/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PH7 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page